| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080767A1 Composition for introduction of nucleic acid |
| 07/22/2009 | EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 07/22/2009 | EP2079761A2 Prevention of aggregation of immunoglobulin light or heavy chains |
| 07/22/2009 | EP2079526A1 Compositions and uses thereof in the treatment of wounds |
| 07/22/2009 | EP2079481A1 Vaccine peptide combinations against cat allergy |
| 07/22/2009 | EP1592704B1 Leukocyte stimulating peptides |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | CN101486754A Small molecule peptide and use thereof |
| 07/21/2009 | US7563871 Polymer-based sustained release device |
| 07/21/2009 | US7563865 Microwave-assisted peptide synthesis |
| 07/21/2009 | US7563864 Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten |
| 07/21/2009 | US7563862 Neural regeneration peptides and methods for their use in treatment of brain damage |
| 07/21/2009 | US7563771 Polypeptide with specific amino acid sequence enhances binding of low-density lipoprotein (LDL) or very low density lipoprotein (VLDL) to a cell, thus reducing the cholesterol and other cardiovascular disorders |
| 07/21/2009 | CA2329144C New peptide fragments for protein purification |
| 07/21/2009 | CA2133834C Process for preparing modified proteins |
| 07/16/2009 | WO2009088022A1 Novel cancer marker, and diagnosis using the same |
| 07/16/2009 | WO2009004315A8 Isolated peptides and uses thereof |
| 07/16/2009 | WO2008114037A8 Treatment of inflammation and/or endotoxic shock |
| 07/16/2009 | WO2008040111A8 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/16/2009 | WO2007107654A8 Cyclopeptide with anti-cancer activity derived from collagen type iv |
| 07/16/2009 | WO2007098611A8 Compositions for treatment of cancer |
| 07/16/2009 | US20090181900 Novel peptides and methods for the treatment of inflammatory disease |
| 07/16/2009 | US20090181899 Low-molecular weight peptides inhibiting ion channel activity |
| 07/16/2009 | US20090181897 Cxcr4 antagonist and use thereof |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090181418 Peptide able to break the m-p53/p63, m-p53/p73 and m-p53/respective isoform proteins complex formed in the tumor cells and uses thereof in the pharmacological field |
| 07/16/2009 | US20090180958 Diagnostic and therapeutic agents |
| 07/15/2009 | EP2078034A2 Synthesis of carbohydrate-templated amino acids and methods of using same |
| 07/15/2009 | EP1773868B1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease |
| 07/15/2009 | CN101481406A H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN100513419C Polypeptide for inhibiting p38 kinase activity and its application |
| 07/15/2009 | CN100513418C Peptides, fragments and derivatives thereof for promoting cell adhesion and spreading |
| 07/15/2009 | CN100512879C Conjugate having cleavable linkage for use in liposome |
| 07/14/2009 | US7560586 Acid and ester compounds and methods of using the same |
| 07/14/2009 | US7560428 Hair growth promoting oligopeptides |
| 07/14/2009 | US7560227 Biomarkers of vulnerable atherosclerotic plaques and methods of use |
| 07/14/2009 | US7560110 Radioimmunotherapy; antibody fragment having at least one arm that specifically binds a targeted tissue and at least one other arm that specifically binds a targetable construct |
| 07/14/2009 | US7560102 Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease |
| 07/14/2009 | US7560095 Cancer specific monoclonal antibodies |
| 07/14/2009 | CA2235721C Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 07/09/2009 | WO2009086132A2 Design of spacers to increase the expression of recombinant fusion proteins |
| 07/09/2009 | WO2009086125A2 Affinity tag nucleic acid and protein compositions, and processes for using same |
| 07/09/2009 | WO2009085096A2 Non-leaching, non-fouling antimicrobial coatings |
| 07/09/2009 | WO2009083663A2 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof |
| 07/09/2009 | WO2008040190A8 Small peptides for anti-angiogenesis and use thereof |
| 07/09/2009 | WO2007129999A8 Antiproliferative peptides and antibodies for their detection |
| 07/09/2009 | US20090176967 Conjugation of FVII |
| 07/09/2009 | US20090176966 Natural IGM Antibodies and Inhibitors Thereof |
| 07/09/2009 | US20090176965 Sericin Having Improved Antioxidant and Tyrosinase Inhibitive Abilities by Irradiation, and Methods of Making and Using the Same |
| 07/09/2009 | US20090176964 Stabilized Alpha Helical Peptides and Uses Thereof |
| 07/09/2009 | US20090176716 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 07/09/2009 | US20090176712 Peptides with Efficacy in Rescuing Melanocortin-4 Receptor Polymorphic Agonist Signaling |
| 07/09/2009 | US20090176710 Complex for transferring an anionic substance into a cell |
| 07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090175981 Compositions, methods and uses for a novel family of peptides |
| 07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
| 07/09/2009 | US20090175873 Inhibiting tumor cell invasion, metastasis and angiogenesis |
| 07/09/2009 | US20090175870 Ykl-40 monoclonal authority |
| 07/09/2009 | CA2701991A1 Cyclic peptides comprising at least one aza-.beta.3-aminoacyl residue and uses thereof |
| 07/08/2009 | EP2077278A1 Peptide derived from neurotensin receptor 3 and use in the treatment of psychiatric disorders |
| 07/08/2009 | EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/08/2009 | EP2076535A2 Receptor(sstr2)-selective somatostatin antagonists |
| 07/08/2009 | EP2076529A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 07/08/2009 | EP2076528A1 Purification processes of echinocandin-type compounds |
| 07/08/2009 | EP2076276A2 Sol-gel materials for cellular modulation |
| 07/08/2009 | CN101475631A Liquid phase synthesizing method for bivalirudin |
| 07/08/2009 | CN101475630A Bloody noun antibacterial peptide temporin-La, genes thereof and use in pharmacy |
| 07/08/2009 | CN101475629A Preparation of stable isotope 15N labeling octapeptide GFL |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509784C Inhibitors of hepatitis C virus ns3/ns4a serine protease |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/08/2009 | CN100509053C Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 07/07/2009 | US7556960 Pseudomycin production by pseudomonas syringae |
| 07/07/2009 | US7556813 Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
| 07/07/2009 | CA2358227C Process for producing an amide compound |
| 07/07/2009 | CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/07/2009 | CA2168029C Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/02/2009 | WO2009079792A1 Recovery of hydrophobic peptides from oils |
| 07/02/2009 | WO2009079790A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | WO2009041830A3 Cell-permeabilising peptides and polypeptides for microbial cells |
| 07/02/2009 | WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual |
| 07/02/2009 | US20090171069 Peptides And Apl-Type Derivatives Of Hsp60 And Pharmaceutical Compositions |
| 07/02/2009 | US20090171068 Method of peptide synthesis |
| 07/02/2009 | US20090170960 Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 07/02/2009 | US20090170792 Peptide ligands |
| 07/02/2009 | US20090170779 cell adhesion molecule determined to effect platelet aggregation, secretion, platelet spreading and cellular adhesion; thrombosis, atherosclerosis, heart attacks, stroke and other clinical disorders involving thrombus formation |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170756 Chimeric natriuretic peptides |
| 07/02/2009 | US20090170755 Cyclic Peptide Compounds |
| 07/02/2009 | US20090170722 Methods of constructing and screening diverse expression libraries |
| 07/02/2009 | US20090170163 Spacers to increase the expression of recombinant fusion proteins |
| 07/02/2009 | US20090169598 Treatment of bacterial infections |
| 07/02/2009 | US20090169574 Heteroclitic analogs and related methods |
| 07/02/2009 | US20090169573 T-Cell Stimulatory Peptides From The Melanoma-Associated Chondroitin Sulfate Proteoglycan And Their Use |
| 07/02/2009 | US20090169559 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 07/02/2009 | US20090169509 O-linked glycosylation of peptides |
| 07/02/2009 | US20090169491 Peptides Having Activities of Insulin Like Growth Factor-1 and their Uses |